Achar J, Seddon JA, Knight GM, Dodd PJ, et al. Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. Eur Respir J 2023 Nov 9:2300969. doi: 10.1183/13993003.00969-2023.
PMID: 37945035